US 11021545
Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents
granted A61KA61K31/506A61K31/7105
Quick answer
US patent 11021545 (Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents) held by The Regents of the University of California expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/506, A61K31/7105, A61K45/06